- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biofrontera Inc (BFRI)
Biofrontera Inc stock price live, this page displays NASDAQ BFRI stock exchange data. View the BFRI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biofrontera Inc real time stock price chart below.
What Is the Biofrontera Inc Stock Price Today?
The Biofrontera Inc stock price today is 1.5900.
What Is the Stock Symbol for Biofrontera Inc?
The stock symbol for Biofrontera Inc is "BFRI."
What Stock Exchange Does Biofrontera Inc Trade On?
Biofrontera Inc is listed and trades on the NASDAQ stock exchange.
Is Biofrontera Inc a Good Stock to Buy?
Determining whether Biofrontera Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BFRI quote. (ISIN: US09077D2099)
What Is the Biofrontera Inc Stock Price Today?
The Biofrontera Inc stock price today is 1.5900.
What Is the Stock Symbol for Biofrontera Inc?
The stock symbol for Biofrontera Inc is "BFRI."
What Stock Exchange Does Biofrontera Inc Trade On?
Biofrontera Inc is listed and trades on the NASDAQ stock exchange.
Is Biofrontera Inc a Good Stock to Buy?
Determining whether Biofrontera Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BFRI quote. (ISIN: US09077D2099)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.5100
1.6100
52 wk Range
0.5547
1.6100
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.51001.6100
52 wk Range
0.55471.6100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BFRI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
6.0000
Upside
+277.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Form 8K Biofrontera Inc For: 13 August- Investing.com
Form 4 Biofrontera Inc For: 29 July- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.0000
(+277.36% Upside)
Biofrontera Inc Earnings Call Summary for Q2/2026
- Biofrontera Q2 2026 revenue hit $12.0M vs. $10.5M forecast, up 32.9% YoY; net loss $0.05/share beat est. $0.14 loss; shares surged 9.6% to $1.37.
- Gross margin expanded to 80% from 71% YoY on new cost structure; adjusted EBITDA loss narrowed to $0.2M from $5.1M; company called it strongest Q2 ever.
- FDA set Sept. 28, 2026 action date for Ameluz sBCC approval, first PDT for cancerous skin tumors; full launch expected Q1 2027 following Q4 2026 outreach.
- Company plans Q3 2026 filing for actinic keratosis label expansion with expected Q3 2027 approval; maintains full-year 2026 revenue guidance despite ITC ruling.
- Cash position of $4.7M raises liquidity concerns amid ongoing burn; CFO targets 2026 breakeven via revenue growth, $1M milestone payment, potential credit facility.
Last Updated: 2026-08-13, 11:10 a/m
Read Full TranscriptEarnings
Latest Release
Aug 13, 2026
EPS / Forecast
-0.05 / -0.14
Revenue / Forecast
12M / 10.5M
Compare BFRI to Peers and Sector
Metrics to compare | BFRI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBFRIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.7x | −1.6x | −0.4x | |
PEG Ratio | −0.05 | 0.01 | 0.00 | |
Price/Book | 4.0x | 1.9x | 2.6x | |
Price / LTM Sales | 0.5x | 2.6x | 3.1x | |
Upside (Analyst Target) | 277.4% | 432.3% | 48.1% | |
Fair Value Upside | Unlock | 0.0% | 6.3% | Unlock |
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Biofrontera (BFRI) Stock Price Today?
The Biofrontera stock price today is 1.5900 USD.
What Stock Exchange Does Biofrontera Trade On?
Biofrontera is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Biofrontera?
The stock symbol for Biofrontera is "BFRI."
What Is the Biofrontera Market Cap?
As of today, Biofrontera market cap is 23.6200M USD.
What Is Biofrontera's Earnings Per Share (TTM)?
The Biofrontera EPS (TTM) is -0.5407.
When Is the Next Biofrontera Earnings Date?
Biofrontera will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is BFRI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Biofrontera Stock Split?
Biofrontera has split 1 times.
How Many Employees Does Biofrontera Have?
Biofrontera has 89 employees.
What is the current trading status of Biofrontera (BFRI)?
As of Aug 30, 2026, Biofrontera (BFRI) is trading at a price of 1.5900 USD, with a previous close of 1.4900 USD. The stock has fluctuated within a day range of 1.5100 USD to 1.6100 USD, while its 52-week range spans from 0.5547 USD to 1.6100 USD.
What Is Biofrontera (BFRI) Price Target According to Analysts?
The average 12-month price target for Biofrontera is 6.0000 USD, with a high estimate of 9 USD and a low estimate of 3 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +277.36% Upside potential.
What Is the BFRI Premarket Price?
BFRI's last pre-market stock price is 1.5500 USD. The pre-market share volume is 45,220.0000, and the stock has decreased by 0.0600, or 4.0300%.
What Is the BFRI After Hours Price?
BFRI's last after hours stock price is 1.5802 USD, the stock has decreased by -0.0098, or -0.6200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.